These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8664171

  • 1. Variation in 1,25-dihydroxyvitamin D3 regulation of proliferation and alkaline phosphatase activity in late-passage rat osteoblastic cell lines.
    Murray S, Glackin C, Murray E.
    J Steroid Biochem Mol Biol; 1993 Aug; 46(2):227-33. PubMed ID: 8664171
    [Abstract] [Full Text] [Related]

  • 2. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol.
    Rao LG, Sutherland MK, Reddy GS, Siu-Caldera ML, Uskokovic MR, Murray TM.
    Bone; 1996 Dec; 19(6):621-7. PubMed ID: 8968029
    [Abstract] [Full Text] [Related]

  • 3. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
    Grigoriadis AE, Petkovich PM, Rosenthal EE, Heersche JN.
    Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
    [Abstract] [Full Text] [Related]

  • 4. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ, Lee YY, Pakkala S, de Vos S, Elstner E, Norman AW, Green J, Uskokovic M, Koeffler HP.
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [Abstract] [Full Text] [Related]

  • 5. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.
    Cross HS, Farsoudi KH, Peterlik M.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):105-10. PubMed ID: 8446178
    [Abstract] [Full Text] [Related]

  • 6. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
    Spiess YH, Price PA, Deftos JL, Manolagas SC.
    Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
    [Abstract] [Full Text] [Related]

  • 7. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T, Simoura T, Osahune N, Uchida Y, Sakuma T, Nemoto N, Kozakai A, Takamura T, Yamazaki R, Higuchi S, Chiba H, Iba K, Sawada N.
    Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
    [Abstract] [Full Text] [Related]

  • 8. Treatment with 1,25-dihydroxyvitamin D3 reduces impairment of human osteoblast functions during cellular aging in culture.
    Kveiborg M, Rattan SI, Clark BF, Eriksen EF, Kassem M.
    J Cell Physiol; 2001 Feb; 186(2):298-306. PubMed ID: 11169466
    [Abstract] [Full Text] [Related]

  • 9. 1 alpha, 25-Dihydroxyvitamin D3 and analogues of vitamin D3 induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria.
    Haneji T, Kurihara N, Ikeda K, Kumegawa M.
    J Biochem; 1983 Oct; 94(4):1127-32. PubMed ID: 6317662
    [Abstract] [Full Text] [Related]

  • 10. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y, Pike JW, Koeffler HP.
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
    Pakkala S, de Vos S, Elstner E, Rude RK, Uskokovic M, Binderup L, Koeffler HP.
    Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of action of 1,25-dihydroxyvitamin D3-induced stimulation of alkaline phosphatase in cultured osteoblast-like cells.
    Manolagas SC, Spiess YH, Burton DW, Deftos LJ.
    Mol Cell Endocrinol; 1983 Nov; 33(1):27-36. PubMed ID: 6357897
    [Abstract] [Full Text] [Related]

  • 13. 1,25 Dihydroxyvitamin D3 is required for growth-independent expression of alkaline phosphatase in cultured rat osteoblasts.
    Fritsch J, Grosse B, Lieberherr M, Balsan S.
    Calcif Tissue Int; 1985 Dec; 37(6):639-45. PubMed ID: 3937589
    [Abstract] [Full Text] [Related]

  • 14. Effects of diastereoisomers of 1,25-dihydroxyvitamin D3-26,23-lactone on alkaline phosphatase and collagen synthesis in osteoblastic cells.
    Ishizuka S, Kiyoki M, Kurihara N, Hakeda Y, Ikeda K, Kumegawa M, Norman AW.
    Mol Cell Endocrinol; 1988 Jan; 55(1):77-86. PubMed ID: 2834243
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical localization of the estrogen receptor in human osteoblastic SaOS-2 cells: association of receptor levels with alkaline phosphatase activity.
    Sutherland MK, Hui DU, Rao LG, Wylie JN, Murray TM.
    Bone; 1996 Apr; 18(4):361-9. PubMed ID: 8726395
    [Abstract] [Full Text] [Related]

  • 16. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
    Sterck JG, Klein-Nulend J, Burger EH, Lips P.
    J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
    [Abstract] [Full Text] [Related]

  • 17. 1,25-Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells.
    Manolagas SC, Burton DW, Deftos LJ.
    J Biol Chem; 1981 Jul 25; 256(14):7115-7. PubMed ID: 6941964
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of cellular alkaline phosphatase activity and its messenger RNA level in a human osteosarcoma cell line by 1,25-dihydroxyvitamin D3.
    Kyeyune-Nyombi E, Lau KH, Baylink DJ, Strong DD.
    Arch Biochem Biophys; 1989 Dec 25; 275(2):363-70. PubMed ID: 2596847
    [Abstract] [Full Text] [Related]

  • 19. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
    Scheven BA, van der Veen MJ, Damen CA, Lafeber FP, Van Rijn HJ, Bijlsma JW, Duursma SA.
    J Bone Miner Res; 1995 Jun 25; 10(6):874-80. PubMed ID: 7572311
    [Abstract] [Full Text] [Related]

  • 20. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
    Lohmann CH, Bonewald LF, Sisk MA, Sylvia VL, Cochran DL, Dean DD, Boyan BD, Schwartz Z.
    J Bone Miner Res; 2000 Jun 25; 15(6):1169-80. PubMed ID: 10841186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.